News

Analysts highlighted momentum in oncology and MedTech, with Wells Fargo calling the second-half growth acceleration “achievable” and Morgan Stanley noting visibility risks from drug pricing and tariff ...
Q2 2025 Management View CEO David M. Solomon reported, "We delivered a strong performance in the second quarter, generating net revenues of $14.6 billion, earnings per share of $10.91 and an ROE of 12 ...